Boston Scientific, Inc. BSX has obtained a CE Mark for the ACURATE Prime Aortic Valve System — the newest transcatheter aortic valve replacement (TAVR) technology in its structural heart portfolio.
Original Image Link
Source:www.msn.com
Original Image Link
Source:www.msn.com
Posted: 2024-08-29 08:49:00